Management strategies for candidates for protease inhibitors and requiring treatment for Mycobacterium tuberculosis. TB/HIV Advisory Committee.
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002170:Canada; D004347:Drug Interactions; D005260:Female; D017408:Guidelines as Topic; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D012293:Rifampin / Q000627:therapeutic use; D012882:Skin Tests; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D017320:HIV Protease Inhibitors; D012293:Rifampin